Literature DB >> 27364410

Virus reactivations after autologous hematopoietic stem cell transplantation detected by multiplex PCR assay.

Natsuko Inazawa1, Tsukasa Hori2, Masanori Nojima3, Makoto Saito2, Keita Igarashi2, Masaki Yamamoto2, Norio Shimizu4, Yuko Yoto2, Hiroyuki Tsutsumi2.   

Abstract

Several studies have indicated that viral reactivations following allogeneic hematopoietic stem cell transplantation (allo-HSCT) are frequent, but viral reactivations after autologous HSCT (auto-HSCT) have not been investigated in detail. We performed multiplex polymerase chain reaction (PCR) assay to examine multiple viral reactivations simultaneously in 24 patients undergoing auto-HSCT between September 2010 and December 2012. Weekly whole blood samples were collected from pre- to 42 days post-HSCT, and tested for the following 13 viruses; herpes simplex virus 1 (HSV-1), HSV-2, varicella-zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), HHV-7, HHV-8, adeno virus (ADV), BK virus (BKV), JC virus (JCV), parvovirus B19 (B19V), and hepatitis B virus (HBV).  Fifteen (63%) patients had at least one type of viral reactivation. HHV6 (n = 10; 41.7%) was most frequently detected followed by EBV (n = 7; 29.2%). HHV-6 peaked on day 21 after HSCT and promptly declined. In addition, HBV, CMV, HHV7, and B19V were each detected in one patient. HHV6 reactivation was detected in almost half the auto-HSCT patients, which was similar to the incidence in allo-HSCT patients. The incidence of EBV was unexpectedly high. Viral infections in patients undergoing auto-HSCT were higher than previously reported in other studies. Although there were no particular complications of viral infection, we should pay attention to possible viral reactivations in auto-HSCT patients. J. Med. Virol. 89:358-362, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  autologous hematopoietic stem cell transplantation; multiplex PCR; virus infection

Mesh:

Year:  2016        PMID: 27364410     DOI: 10.1002/jmv.24621

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  16 in total

1.  Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.

Authors:  Daniel B Reeves; Christopher W Peterson; Hans-Peter Kiem; Joshua T Schiffer
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

Review 2.  Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Marie-Céline Zanella; Samuel Cordey; Laurent Kaiser
Journal:  Clin Microbiol Rev       Date:  2020-08-26       Impact factor: 26.132

3.  Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation.

Authors:  Michael Scordo; Sejal M Morjaria; Eric R Littmann; Ankush Bhatia; Helen H Chung; Molly Maloy; Lisa M DeAngelis; Sergio A Giralt; Ying Taur; Craig S Sauter
Journal:  Biol Blood Marrow Transplant       Date:  2018-04-18       Impact factor: 5.742

4.  Severe Refractory Anaemia and Fever of Unknow Origin: Human Parvovirus B19 Reactivation.

Authors:  Joaquín Escobar-Sevilla; Antonio Bustos Merlo; Carmen Garcia Martínez; Juan Diego Mediavilla Garcia
Journal:  Eur J Case Rep Intern Med       Date:  2020-06-25

Review 5.  Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation.

Authors:  Jan Styczynski
Journal:  Infect Dis Ther       Date:  2017-12-04

6.  Polyomavirus Nephropathy in Autologous Stem Cell Transplantation.

Authors:  Tushar Malavade; Clarissa Cassol; Rohan John; Shahid Husain; Christine I Chen; Christopher T Chan
Journal:  Kidney Int Rep       Date:  2018-01-05

7.  Impact of CMV Infection on Natural Killer Cell Clonal Repertoire in CMV-Naïve Rhesus Macaques.

Authors:  Lauren L Truitt; Di Yang; Diego A Espinoza; Xing Fan; Daniel R Ram; Matilda J Moström; Dollnovan Tran; Lesli M Sprehe; R Keith Reeves; Robert E Donahue; Amitinder Kaur; Cynthia E Dunbar; Chuanfeng Wu
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

8.  Persistent Roseoloviruses Infection in Adult Patients with Epilepsy.

Authors:  Santa Rasa-Dzelzkaleja; Sabine Gravelsina; Svetlana Chapenko; Zaiga-Nora Krukle; Simons Svirskis; Normunds Suna; Elena Kashuba; Guntis Karelis; Modra Murovska
Journal:  Brain Sci       Date:  2020-05-11

Review 9.  Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  Maximilian Christopeit; Martin Schmidt-Hieber; Rosanne Sprute; Oliver A Cornely; Georg Maschmeyer; Dieter Buchheidt; Marcus Hentrich; Meinolf Karthaus; Olaf Penack; Markus Ruhnke; Florian Weissinger
Journal:  Ann Hematol       Date:  2020-10-20       Impact factor: 3.673

Review 10.  Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

Authors:  Anne Marit Sponaas; Anders Waage; Esten N Vandsemb; Kristine Misund; Magne Børset; Anders Sundan; Tobias Schmidt Slørdahl; Therese Standal
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.